header bar
  MyelomaLinks - Your Link to the Latest Myeloma News  


JULY 2009 800.955.4572 Email the IRC Forward to a Friend
 

Welcome to MyelomaLinks, your monthly source of myeloma news, research updates, clinical trials and events of The Leukemia & Lymphoma Society (LLS). For even more information, regularly visit our Patient Services and Disease Information Web sections.

news image

Latest Myeloma News

Considering Longer Chemotherapy  
Doctors and pharmaceutical companies are moving toward treating cancer patients with drugs continuously, even when they may not urgently need them.

Combination therapy effective for previously untreated Waldenström macroglobulinemia
Various combinations of bortezomib, dexamethasone, and rituximab (BDR) have been shown in preclinical studies to have additive and possibly synergistic effects in killing tumor cells in lymphoma and myeloma models
.

LLS Features    ::READ MORE::
.....................................................................................................................................

Research Roundup
   ::READ MORE::
.....................................................................................................................................
IRC Question of the Month  
:: READ MORE::


Inspirational Stories

Inspirational ImageLearn how individuals touched by blood cancer cope. LLS's LifeMosaic Web feature offers hundreds of inspiring stories by patients and families. Read them or submit your own.

Here to Help

Visit the LLS Web site www.LLS.org regularly for even more information. Many of our education programs are archived free of charge for convenient access 24/7.

If you haven't found what you're looking for in MyelomaLinks , please call our Information Resource Center (IRC) to speak with trained information specialists. IRC staff are available Monday through Friday, 9 a.m. to 6 p.m. ET, toll free at (800) 955-4572; email
infocenter@lls.org; or click the "Live Patient Help" button on the www.LLS.org homepage.

Please consider a tax-deductible gift to LLS. Donate online today and help us make a difference in the lives of patients and their families.

Help for Patients with a Difficult Blood Cancer
The Leukemia & Lymphoma Society offers Co-Pay Assistance for Myeloma Patients.
:: READ MORE::

 

 

 

Researcher Image

Clinical Trials
We invite you to use our LLS-supported TrialCheck® Web site, a clinical trial search service that offers patients and caregivers immediate access to listings of all myeloma clinical trials. Answer just a few simple questions and a list of available clinical trials related to your cancer will appear in an easy-to-read list of search results. 

You may also want to visit the National Cancer Institute's Cancer Trials Support Unit, providing resources and information on Phase III cancer treatment trials supported by the National Cancer Institute.  ::SELECTED TRIALS::



Newsfeeds & Podcasts

Now you can get RSS Feeds and Podcasts from LLS.
:: CLICK HERE TO SIGN UP::

RSS - XML - Podcast - iTunes

Free eNewsletters
Free LLS eNewsletters deliver the latest information on research and treatment options, patient services programs and fundraising events.
::CLICK HERE TO SIGN UP::


bottom bar


LLS Features

calendar image

My Personal Clinical Trials Journey
Participate in this personalized and interactive program that follows the stories and experiences of three cancer survivors who have participated in clinical trials.

Co-Pay Assistance Program
Patients with myeloma who have difficulty paying for or simply cannot afford their prescription drug co-pays or health insurance premiums can now apply for up to $5,000 in assistance from LLS.

Archived Educational Events
Experience archived  Myeloma teleconferences and Webcasts free of charge, anytime. Also, the opportunity to download the audio file, read the written transcript or listen online to the recent program Emerging Therapies in Leukemia, Lymphoma & Myeloma are now available on the LLS Web site.

LLS Advocacy
LLS's advocacy team represents the needs of cancer patients and their families in Washington, DC and state capitals throughout the United States. We need your help. Join our Advocates Network and make your voice heard. 

TAKE ACTION: Urge Your Representative to Support Increased Cancer Research Funding - Tell your elected officials that to win the war on cancer, they need to fund the war on cancer!

Free Materials
New detailed and basic myeloma booklets are now available in English and Spanish. To view and order, see Myeloma , The Myeloma Guide, Mieloma and La guía sobre el myeloma.
 
Patient Services Survey
Please give us your feedback by completing LLS Disease & Treatment Publications - Survey for Patients, Family and Friends.

LLS Blog

The Leukemia & Lymphoma Society is committed to curing blood cancers and helping patients and their families. Learn the many ways you can help advance LLS's mission. 

> Back to the top

Research Roundup

links_image_micro2

Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma.  ::READ MORE::

Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trial.  ::READ MORE::

Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial.  ::READ MORE::

Fenretinide inhibits myeloma cell growth, osteoclastogenesis and osteoclast viability.  ::READ MORE::

> Back to the top

Clinical Trials
Clinical Trials Image

Selected Trials

Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma  ::READ MORE::

Phase III: Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients with Multiple Myeloma Previously Treated With Dexamethasone  ::READ MORE::

Randomized Phase 3b Study in Previously Untreated Multiple Myeloma Patients: VELCADE, Thalidomide, and Dexamethasone Versus VELCADE and Dexamethasone Versus VELCADE, Melphalan, and Prednisone  ::READ MORE::

Phase III: American Ginseng in Treating Patients with Fatigue Caused by Cancer  ::READ MORE::

> Back to the top

IRC Question of the Month
Q&A

Q: I have gotten a side effect from chemotherapy called peripheral neuropathy, are there any treatments for this condition, as it affects my daily life?

A: Peripheral neuropathy (PN) is the term for damage to nerves of the peripheral nervous system, which transmits information from the brain and spinal cord to other parts of the body. PN is estimated to affect 10 to 20 percent of people with cancer and can be caused by certain chemotherapeutic agents, such as vincristine (Oncovin®), bortezomib (Velcade®), thalidomide (Thalomid®), lenalidomide (Revlimid®), cytarabine (Cytosar-U®), interferon (multiple brand names) or methotrexate (multiple brand names). Radiation therapy may cause nerve injury, although it may take several years for symptoms to appear. Shingles, a rash that may develop in people with weakened immune systems, may also result in neuropathy. PN may also be a symptom of certain diseases, such as myeloma.

Some causes of PN are not associated with cancer. PN may be inherited or it can be a symptom of certain diseases or conditions. It is important to let your doctor know if you already have symptoms of neuropathy before starting treatment, or if you have any of the conditions that are associated with PN, including diabetes, nerve compression caused by vertebral fractures or vitamin deficiencies, particularly folate or vitamin B12, autoimmune diseases, such as lupus and rheumatoid arthritis, hypothyroidism or kidney disease.

While a person is undergoing cancer treatment, his or her doctor may give prescribe certain medications and/or vitamins to help prevent neuropathy. Be sure to talk with your doctor before starting any over-the-counter medications, vitamins, or supplements on your own. Patients should seek medical advice as soon as possible if they experience numbness, tingling, burning, coldness or weakness in the arms or legs. These may be symptoms of PN.

With medical advice, patients who develop PN as a result of chemotherapy may be helped by taking a reduced dosage of the prescribed drugs or stopping the drugs completely. Treatment-caused PN may gradually decrease after treatment is completed. In some cases, the symptoms may persist.  Other therapies for PN depend on its cause and related symptoms. Many people recover fully from the disorder over time, whether it is in a few months or a few years. Sometimes, the condition may be more difficult to cure and may require long-term management. Your doctor will work to diagnose and eliminate the cause of your neuropathy and manage symptoms.

These safety tips from the American Society of Clinical Oncology at Cancer.Net may help people with PN who have sensory or motor difficulties to avoid injury at home:

  • Keep all rooms, hallways, and stairways well lit.
  • Install handrails on both sides of stairways.
  • Remove small area rugs and any other clutter that you could trip over or slip on.
  • Install grab bars in the shower or handgrips in the tub, and lay down skid-free mats.
  • Use a thermometer to check that any water you bathe in or use is below 110 degrees Fahrenheit, or set your water heater accordingly.
  • Clean up any spilled water or liquids immediately.
  • Use non-breakable dishes.
  • Use potholders while cooking and rubber gloves when washing dishes.
  • If you drive, make sure you can fully feel the gas and brake pedals, and the steering wheel, and that you can quickly move your foot from the gas to the brake.
  • If prescribed, use a cane or walker when moving from one room to the other .

Please call our Information Resource Center (IRC) to speak with a trained information specialist. IRC staff are available Monday through Friday, 9 a.m. to 6 p.m. ET, toll free at (800) 955-4572. Contact us online or click the "Live Patient Help" button on the www.LLS.org homepage.

> Back to the top

Supported by an unrestricted
educational grant from
Allos Therapeutics, Inc Cephalon Oncology
Donate Now
Contact Us: The Leukemia & Lymphoma Society, 1311 Mamaroneck Ave., White Plains, NY 10605, (800) 955-4572
Visit our e-Store & Special Offers page where you can support businesses that support LLS.